Lord, Abbett & Co
CELL

Lord, Abbett & Co’s PhenomeX Inc. Common Stock CELL Stock Holding History

Lord, Abbett & Co’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-439,994
Closed -$22.1M – 728
2021
Q1 		$22.1M Buy
439,994
+10,354
+2% +$706K 0.06% 403
2020
Q4 		$38.4M Buy
429,640
+80,760
+23% +$6.79M 0.1% 303
2020
Q3 		$26.6M Buy
+348,880
New +$22.2M 0.09% 325

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Lord, Abbett & Co's CELL Position: Q2 2021 in Review

Lord, Abbett & Co sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2021, closing a stake of 439,994 shares — an estimated $22.1M sold.

Lord, Abbett & Co first reported a position in CELL in Q3 2020 and held it in 3 quarters. The position peaked at $38.4M in Q4 2020. 156 funds tracked by Wall St. Rank hold CELL as of Q2 2021.

  • Lord, Abbett & Co reported no remaining PhenomeX Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Lord, Abbett & Co sold 439,994 PhenomeX Inc. Common Stock shares in Q2 2021, an estimated $22.1M.
  • Lord, Abbett & Co first reported a position in PhenomeX Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Lord, Abbett & Co's PhenomeX Inc. Common Stock position peaked at $38.4M in Q4 2020.
  • 156 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2021.

Based on Lord, Abbett & Co's 13F filing for Q2 2021, filed 11 Aug 2021.